Q4 resultsAll in all not too bad. Revenue of 1 million (would have liked to see another 200k or so) but a great job at controlling loss to just 345K.
Cash on the balance sheet of just under 2.2 million looked a little worrying at first, but receivables, inventories, and deposits increased by 1.4 million compared to Q3. That is still almost 3.6 million (quarter to quarter comparison) or 6.3 cents/share, and total assets actually increased a touch to 8.8 million or 15.7 cents a share.
I did like the tone of the report as the CEO expects product awareness to increase as a result of the pandemic and they have a plan to increase product margins, even if the tariffs stay.
I personally think the numbers are good enough to create some investor confidence.
With vaccinations underway, I still think the company returns to profitability in fiscal 2021.
GLTA